The dark side of targeted therapy

Eur Urol. 2011 Apr;59(4):541-2. doi: 10.1016/j.eururo.2011.01.041. Epub 2011 Feb 1.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Carcinoma, Renal Cell / drug therapy*
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Kidney Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Immunosuppressive Agents